Expression of neutrophil SOD2 is reduced after lipopolysaccharide stimulation: A potential cause of neutrophil dysfunction in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2195-2201

  Olsson, Jenny ^a,c   Jacobson, Therese A S ^b   Paulsson, Josefin M ^b   Dadfar, Elham ^b   Moshfegh, Ali ^b   Jacobson, Stefan H ^c   Lundahl, Joachim ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

chemokines; chronic kidney disease; leucocyte dysfunction; respiratory burst; SOD2

Indexed keywords

CD11B ANTIGEN; LIPOPOLYSACCHARIDE; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN HL 60; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IL 1R1 GENE; IL 1R2 GENE; IL1A GENE; IL8RA GENE; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; SOD2 GENE; UPREGULATION;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HL-60 CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHORBOL ESTERS; RESPIRATORY BURST; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 79959929539     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq673     Document Type: Article

References (40)

1. Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006; 13: 199-204. (Pubitemid 43947730)
2. Graff LR, Franklin KK, Witt L et al. Antimicrobial therapy of gramnegative bacteremia at two university-affiliated medical centers. Am J Med 2002; 112: 204-211.
3. Horl WH. Neutrophil function in renal failure. Adv Nephrol Necker Hosp 2001; 31: 173-192.
4. Cohen G, Rudnicki M, Horl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48-S52. (Pubitemid 32144069)
5. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943. (Pubitemid 36513344)
6. Vanholder R, Meert N, Schepers E et al. Uremic toxins: do we know enough to explain uremiA Blood Purif 2008; 26: 77-81.
7. Sardenberg C, Suassuna P, Andreoli MC et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006; 21: 160-165. (Pubitemid 43057125)
8. Vanholder R, De Smet R, Jacobs Vet al. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant 1994; 9: 1271-1278. (Pubitemid 24283653)
9. Vanholder R, De Smet R,Waterloos MA et al. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995; 47: 510-517.
10. Vanholder R, van Loo A, Dhondt AM et al. Influence of uraemia and haemodialysis on host defence and infection. Nephrol Dial Transplant 1996; 11: 593-598. (Pubitemid 26114538)
11. Sela S, Shurtz-Swirski R, Cohen-Mazor M et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-2438. (Pubitemid 41725061)
12. Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1995; 5: 1697-1702.
13. Theilgaard-Monch K, Porse BT, Borregaard N. Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 2006; 18: 54-60. (Pubitemid 43049648)
14. Coldren CD, Nick JA, Poch KR et al. Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1267-L1276. (Pubitemid 44904533)
15. Theilgaard-Monch K, Knudsen S, Follin P et al. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 2004; 172: 7684-7693. (Pubitemid 38747635)
16. Yamashiro S, Kamohara H, Wang JM et al. Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 2001; 69: 698-704. (Pubitemid 32466406)
17. Chertov O, Yang D, Howard OM et al. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68-78.
18. Chaby R. Lipopolysaccharide-binding molecules: transporters, blockers and sensors. Cell Mol Life Sci 2004; 61: 1697-1713. (Pubitemid 39044251)
19. Opal SM, Scannon PJ, Vincent JL et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584-1589. (Pubitemid 29506461)
20. Remer KA, Brcic M, Jungi TW. Toll-like receptor-4 is involved in eliciting an LPS-induced oxidative burst in neutrophils. Immunol Lett 2003; 85: 75-80. (Pubitemid 36009428)
21. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999; 73: 369-509. (Pubitemid 29300434)
22. Cassatella MA, Meda L, Gasperini S et al. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995; 25: 1-5.
23. Fukuzono S, Kato T, Fujita H et al. Granulocyte colony-stimulating factor negatively regulates Toll-like receptor agonist-induced cytokine production in human neutrophils. Arch Biochem Biophys 2010; 495: 144-151.
24. Malcolm KC, Arndt PG, Manos EJ et al. Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 2003; 284: L663-L670. (Pubitemid 36343314)
25. Almkvist J, Faldt J, Dahlgren C et al. Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect Immun 2001; 69: 832-837. (Pubitemid 32109546)
26. Guthrie LA, McPhail LC, Henson PM et al. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984; 160: 1656-1671. (Pubitemid 15193995)
27. Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic Res 2007; 41: 770-778. (Pubitemid 46995258)
28. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002; 33: 337-349. (Pubitemid 34790245)
29. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
30. Birnie GD. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br J Cancer Suppl 1988; 9: 41-45. (Pubitemid 19054738)
31. Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987; 70: 1233-1244. (Pubitemid 18026122)
32. Collins SJ, Ruscetti FW, Gallagher RE et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 2458-2462. (Pubitemid 8346181)
33. Koball S, Korten G, Stange J et al. Biocompatibility assessment of peritoneal dialysis solutions with a new in vitro model of preconditioned human HL60 cells. Artif Organs 2009; 33: 544-550.
34. Park CJ, Gabrielson NP, Pack DWet al. The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-8. Biomaterials 2009; 30: 436-444.
35. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147. (Pubitemid 26086851)
36. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002; 20: S1-S13. (Pubitemid 35174747)
37. McMahan CJ, Slack JL, Mosley B et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991; 10: 2821-2832. (Pubitemid 21905299)
38. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323-340.
39. Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol 2000; 7: 178-182. (Pubitemid 30213152)
40. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490-495 (Pubitemid 27077839)